Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.600
-0.012 (-1.96%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Cytosorbents Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -8.2 | -20.72 | -29.25 | -32.81 | -24.56 | Upgrade
|
| Depreciation & Amortization | 1.63 | 1.74 | 2.02 | 1.13 | 1.13 | Upgrade
|
| Other Amortization | 0.82 | 0.38 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.13 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.66 | 0.33 | 0.66 | 0.64 | - | Upgrade
|
| Stock-Based Compensation | 2.77 | 3.76 | 4.16 | 3.8 | 6.2 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.04 | 0.12 | 0.01 | -0.01 | -0 | Upgrade
|
| Other Operating Activities | -9.07 | 4.34 | -1.91 | 2.45 | 2.58 | Upgrade
|
| Change in Accounts Receivable | 0.42 | -1.72 | -0.25 | -1.29 | 0.42 | Upgrade
|
| Change in Inventory | -2.54 | 0.5 | 0.18 | 0.95 | -2.35 | Upgrade
|
| Change in Accounts Payable | -0.71 | -1.81 | 1.61 | -3.25 | 2.43 | Upgrade
|
| Change in Other Net Operating Assets | 1.79 | -1.35 | 1.1 | 0.03 | 0.15 | Upgrade
|
| Operating Cash Flow | -12.38 | -14.43 | -21.66 | -28.23 | -14.01 | Upgrade
|
| Capital Expenditures | -0.16 | -0.28 | -0.54 | -6.09 | -3.64 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.08 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.33 | -0.39 | -0.4 | -0.37 | -0.64 | Upgrade
|
| Investing Cash Flow | -0.42 | -0.67 | -0.94 | -6.46 | -4.28 | Upgrade
|
| Long-Term Debt Issued | 2.48 | 15 | - | 5 | - | Upgrade
|
| Long-Term Debt Repaid | - | -5 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 2.48 | 10 | - | 5 | - | Upgrade
|
| Issuance of Common Stock | 6.83 | 0.18 | 14.47 | - | 0.81 | Upgrade
|
| Other Financing Activities | - | -0.85 | - | -0.04 | -0.09 | Upgrade
|
| Financing Cash Flow | 9.31 | 9.33 | 14.47 | 4.96 | 0.72 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.49 | -0.09 | -0.1 | -0.26 | -0.02 | Upgrade
|
| Net Cash Flow | -1.99 | -5.85 | -8.22 | -29.99 | -17.6 | Upgrade
|
| Free Cash Flow | -12.54 | -14.71 | -22.19 | -34.32 | -17.65 | Upgrade
|
| Free Cash Flow Margin | -33.84% | -41.33% | -71.39% | -98.94% | -40.88% | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.27 | -0.50 | -0.79 | -0.41 | Upgrade
|
| Cash Interest Paid | 2.08 | 1.29 | 0.38 | - | - | Upgrade
|
| Levered Free Cash Flow | -2.07 | -14.79 | -12.92 | -23.8 | -8.88 | Upgrade
|
| Unlevered Free Cash Flow | -1.26 | -14.29 | -12.82 | -23.8 | -8.88 | Upgrade
|
| Change in Working Capital | -1.03 | -4.38 | 2.65 | -3.56 | 0.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.